PDPN and neoplasm: It has been suggested that the interaction of CLEC-2 with podoplanin, which involves O-glycans, may be involved in promoting tumor growth and/or metastasis, and could therefore be a target for therapeutic intervention (Suzuki-Inoue et al., 2007; Christou et al., 2008; Kato et al., 2008).